November 2017, Vol 7, No 11

Identifying Long-Term Unmet Needs in Survivorship Care

By Meg Barbor, MPH

Survivorship, Survivorship Care

The number of cancer survivors is increasing. To keep up with this trend, survivorship care must evolve and become more efficient, insists Jennifer R. Klemp, PhD, MPH, MA, Director, Cancer Survivorship, University of Kansas Cancer Center, Westwood. Read More ›

Regular CT Scans for NSCLC Follow-Up May Not Be Necessary

By Phoebe Starr

ESMO Highlights

Oncology Practice Trends and Pressures

By Meg Barbor, MPH

Practice Management

An American Society of Clinical Oncology (ASCO) Oncology Practice Trends Survey from 2015 to 2016 revealed that increasing practice or facility expenses, drug pricing, and issues with electronic health records (EHRs) were among the top practice pressures cited by oncologists. Read More ›

Practice-Changing: Nivolumab plus Ipilimumab Beat Sunitinib as First-Line Treatment for Metastatic RCC

By Phoebe Starr

ESMO Highlights

Rucaparib Maintenance Extends Survival in Platinum-Sensitive Ovarian Cancer

By Phoebe Starr

ESMO Highlights

Medications Used for the Treatment of Lung Cancer and Associated ICD-10 Coding

By Kristin A. Esposito, CPhT

Cancer Drug Coding, ICD Codes, Reimbursement

This detailed article of codes related to lung cancer is intended to assist practice managers and other healthcare providers and payers to ensure the proper use of coding and billing information associated with the treatment of patients with lung cancer. Read More ›